Warther Private Wealth LLC Reduces Holdings in CVS Health Co. (NYSE:CVS)

Warther Private Wealth LLC lessened its position in shares of CVS Health Co. (NYSE:CVS) by 77.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,567 shares of the pharmacy operator’s stock after selling 18,780 shares during the quarter. Warther Private Wealth LLC’s holdings in CVS Health were worth $250,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB increased its holdings in CVS Health by 124.1% in the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after purchasing an additional 34,198 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in shares of CVS Health by 61.9% during the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock worth $934,000 after buying an additional 5,679 shares during the period. Sound Income Strategies LLC grew its stake in shares of CVS Health by 7.2% in the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock valued at $151,000 after buying an additional 162 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its stake in CVS Health by 32.5% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 7,805 shares of the pharmacy operator’s stock worth $491,000 after acquiring an additional 1,914 shares in the last quarter. Finally, Procyon Advisors LLC purchased a new position in CVS Health during the 3rd quarter valued at about $202,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have issued reports on CVS shares. Mizuho cut their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Royal Bank of Canada reduced their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Finally, UBS Group reduced their price target on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $67.78.

CVS Health Stock Up 1.3 %

Shares of NYSE:CVS opened at $55.01 on Wednesday. The company has a market cap of $69.23 billion, a price-to-earnings ratio of 13.96, a PEG ratio of 0.60 and a beta of 0.61. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The firm’s 50-day simple moving average is $50.69 and its 200-day simple moving average is $55.95. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.84%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.